Clinical Trial Update: Methylprednisolone Taper After Total Knee Replacement [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a methylprednisolone taper after total knee replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Emory University | Conditions: Knee Arthritis | Phase 4 | Status: COMPLETED